Gayle v. United States

CourtDistrict Court, M.D. Pennsylvania
DecidedMarch 25, 2025
Docket1:23-cv-00861
StatusUnknown

This text of Gayle v. United States (Gayle v. United States) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gayle v. United States, (M.D. Pa. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF PENNSYLVANIA

TYRIN GAYLE, : Plaintiff : No. 1:23-cv-00861 : v. : (Judge Kane) : S. MOWATT, MD, et al., : Defendants :

MEMORANDUM

Currently before the Court is Defendants’ motion to dismiss pro se Plaintiff’s amended complaint or, in the alternative, motion for summary judgment. For the reasons stated below, the Court will grant the motion to dismiss, dismiss Plaintiff’s amended complaint for lack of subject- matter jurisdiction and for the failure to state a plausible claim for relief, and not provide Plaintiff with leave to file a second amended complaint. The Court will also deny the motion for summary judgment as moot and direct the Clerk of Court to close this case. I. BACKGROUND Pro se Plaintiff Tyrin Gayle (“Gayle”), a convicted and sentenced federal prisoner, commenced this action by filing a complaint, an application for leave to proceed in forma pauperis (“IFP Application”), and certified prisoner trust fund account statement, all of which the Clerk of Court docketed on May 24, 2023. See (Doc. Nos. 1–3). In the complaint, Gayle asserted claims for violations of his First and Eight Amendment rights under Bivens v. Six Unknown Named Agents of Federal Bureau of Narcotics, 403 U.S. 388 (1971) and state-law claims for negligence under the Federal Tort Claims Act (“FTCA”) against Defendants United States of America (the “Government”), S. Mowatt, M.D. (“Dr. Mowatt”), Rhea Carey, PA-C (“Carey”), John Keelen, CRNP (“Keelen”), Ann Narcoonis, APN (“Narcoonis”), and Jeremy Simonson, Health Service Assistant (“Simonson”). See (Doc. No. 1 at 1–3). On July 11, 2023, the Court issued a Memorandum and Order which, inter alia, granted the IFP Application, dismissed the complaint, and provided Gayle with leave of Court to file an amended complaint within thirty (30) days. See (Doc. Nos. 6, 7). After receiving an extension of time (Doc. Nos. 8, 9), Gayle timely filed an amended complaint on September 6, 2023, along with separately docketed exhibits.1 (Doc. Nos. 11, 12). Regarding the named Defendants and

the causes of action in the amended complaint, Gayle names the same six (6) Defendants he named in his original complaint; however, he indicates that he is no longer asserting an FTCA claim or Bivens claims for violations of the First Amendment. (Doc. No. 11 at 1–3). Instead, he indicates that he asserts only Bivens claims for alleged violations of his rights under the Eighth and Fourteenth Amendments. (Id. at 1, 10). For relief, Gayle requests an injunction “for an effective treatment to diagnosis [sic] seizure disorder, that is, long-term, ambulatory, video EEG monitoring and a clinical correlation is requested” with a doctor, as well as monetary damages. See (id. at 10). Concerning his factual allegations, Gayle describes events that allegedly occurred

between late-August 2019 through early-March 2023 while he was incarcerated at United States Penitentiary Canaan (“USP Canaan”).2 (Id. at 4–10). Gayle’s allegations start with a medical visit he had with Carey at USP Canaan’s Health Services on August 28, 2019. (Id. at 5). During this visit, Gayle informed Carey that he had experienced seizures following a motor vehicle accident in 2015, and he had two (2) “episodes” earlier that day. (Id.) Based on her evaluation, Carey assessed Gayle as having “Epilepsy/Seizure Disorder,” and he was prescribed 100 mg

1 Gayle submitted his medical records as exhibits. (Doc. No. 12.) Most of Gayle’s allegations in his amended complaint are purported summaries of the contents in those medical records. (Doc. No. 11 at 5–8.)

2 Gayle is currently incarcerated at Federal Correctional Institution McKean. “Phenytoin Sodium ER Capsule” to take three (3) times per day. See (id. at 5; Doc. No. 12 at 2). In addition, lab tests and an on-site CT Scan were ordered. See (Doc. No. 12 at 2). The following day, Gayle appeared at the pill line looking for medications. See (Doc. Nos. 11 at 5; Doc. No. 12 at 4). A Federal Bureau of Prisons (“BOP”) Health Services Clinical

Encounter Administrative Note from Tom Horeis, PharmD (“Dr. Horeis”), states that Gayle had not picked up his medication the prior evening, i.e. after Carey had prescribed Phenytoin to him. See (Doc. No. 12 at 4). Dr. Horeis issued Gayle’s medication to him; however, Gayle indicated that “he was not interested in taking any medication until he knew for sure” what his diagnosis was. See (id.). Although Dr. Horeis explained to Gayle that he was prescribed Phenytoin as a preventative measure, and that Gayle had a follow-up appointment scheduled, Gayle “continued to advise that he was not interested in taking a medication regularly unless he had a test or something of that sort to define his [diagnosis].” See (id.).3 Dr. Horeis urged Gayle to “walk over to sick call to verify [his] follow up and to talk a little more about the medications.” See (id.). Dr. Horeis noted that when the pill line concluded, Gayle was no longer in the room. See

(id.). Dr. Horeis also noted that he would attempt to place Gayle on “call out for tomorrow.” See (id.). On the same date, Gayle had a CT Scan of his brain without contrast performed. (Id. at 5; Doc. No. 11 at 5.) The report from the scan, issued by Phyllis Kapellen, M.D., stated that Gayle’s scan was “[u]nremarkable.” See (Doc. No. 12 at 5).

3 Gayle’s medical records contain numerous abbreviations for terms that are not defined therein. Where possible, the Court has identified the terms for the abbreviations through Taber’s Medical Dictionary Online, available at: https://www.tabers.com/tabersonline, and replaced the abbreviations with the terms in the quoted material from the medical records. Approximately three-and-a-half (3 ½) months later, on December 9, 2019, Gayle met with Dr. Mowatt at Health Services for the Chronic Care Clinic. (Id. at 6; Doc. No. 11 at 4.) Dr. Mowatt’s notes from this visit reflect that Gayle told her that since his motor vehicle accident in 2015, he periodically had episodes “where he bites his tongue, does not remember, [and] feels

tired and confused.” See (Doc. No. 12 at 6). Dr. Mowatt notes that Gayle was scheduled to have an EEG, and since Gayle had “not really been taking the medication regularly,” she wanted him to hold off his medications and “get testing while off [AED]4 to see if abnormal or not.” See (id.; Doc. No. 11 at 5); see also (Doc. No. 11 at 4 (alleging that Dr. Mowatt discontinued medication and ordered testing “because of [Gayle’s] desire not to take medication if[,] as the staff says[,] that [he] does not have seizures”)). Dr. Mowatt also indicates Gayle agreed with her plan and was sleeping on the low bunk. (Doc. No. 12 at 6.) Gayle was evaluated by John Veina, NREMT-P (“Veina”), at Health Services on December 23, 2019, because he “reportedly” had two (2) seizures that day and bit the tip of his tongue. See (id. at 8; Doc. No. 11 at 5). Veina’s administrative notes from this encounter

indicate that Veina spoke to the “Doctor via phone and she stated to start [Gayle] back on his Phenytoin ER 100 MG Cap. 1 Tablet 3 times daily and to be placed on pill line.” See (Doc. No. 12 at 8). Apparently, this was done “without approval from Gayle.” See (Doc. No. 11 at 5).

4 AED refers to an “antiepileptic drug.” See AED, Taber’s Medical Dictionary Online, https://www.tabers.com/tabersonline (last visited February 7, 2025). Later in his complaint, Gayle appears to believe that “AED” refers to an automated external defibrillator. See (Doc. No. 11 at 6 (“Gayle approached Dr. Mowatt while he was in Health Services, questioning why he is no longer on AED [Automated External Defibrillator] . . . .”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Orleans
425 U.S. 807 (Supreme Court, 1976)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Davis v. Passman
442 U.S. 228 (Supreme Court, 1979)
United States v. Mitchell
445 U.S. 535 (Supreme Court, 1980)
Carlson v. Green
446 U.S. 14 (Supreme Court, 1980)
Bush v. Lucas
462 U.S. 367 (Supreme Court, 1983)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Turner v. Safley
482 U.S. 78 (Supreme Court, 1987)
Hazen Paper Co. v. Biggins
507 U.S. 604 (Supreme Court, 1993)
Federal Deposit Insurance v. Meyer
510 U.S. 471 (Supreme Court, 1994)
Correctional Services Corp. v. Malesko
534 U.S. 61 (Supreme Court, 2001)
DaimlerChrysler Corp. v. Cuno
547 U.S. 332 (Supreme Court, 2006)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
In Re Insurance Brokerage Antitrust Litigation
618 F.3d 300 (Third Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Gayle v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gayle-v-united-states-pamd-2025.